NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
NASDAQ · Healthcare · Medical - Devices · US
$1.39
+2.21%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$1.38
From 52W high−78.14%
Volume148915.00
Market cap$12.66M
P/E (TTM)—
P/S (TTM)1.3x
Div yield—
Key dataSep 18, 2026
Open
$1.38
From 52W high
−78.14%
Volume
148915.00
Market cap
$12.66M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.5x
P/E (TTM)
—
RSI (14)
30.5
MomentumView details →
1D Return
+2.21%
YTD Return
−69.89%
SummaryUpdated Jun 1, 2026
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) is a medical technology company founded in 2014 and headquartered in Eden Prairie, Minnesota. The company went public in March 2018 and specializes in developing innovative thin-film electrode technologies for treating neurological disorders. NeuroOne has evolved from a research-stage company to a commercialized medical device manufacturer, with its flagship OneRF ablation system receiving FDA clearance in 2024. The company has established strategic partnerships with major medical device companies, most notably Zimmer Biomet, to distribute its products globally.
Similar companies
Latest newsMore news →